Patent directory · USPTO A61K / A61P
Patents matching “HALOZYME, INC.”
69 pharma patents match "HALOZYME, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 69 pharmaceutical patents matching "HALOZYME, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10588983
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
granted -
US 10328130
Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
granted -
US 10286044
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
granted -
US 10265410
Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects
granted -
US 10137104
Combination therapy with an anti-hyaluronan agent and therapeutic agent
granted -
US 10016491
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
granted -
US 9993529
Stable formulations of a hyaluronan-degrading enzyme
granted -
US 9969998
Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same
granted -
US 9913822
Combination therapy with an anti-hyaluronan agent and therapeutic agent
granted -
US 9878046
Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects
granted -
US 9833498
Methods of treatment of collagen-mediated diseases and conditions
granted -
US 9775889
Methods of treatment of cellulite
granted -
US 9683985
Methods for assessing and identifying or evolving conditionally active therapeutic proteins
granted -
US 9677062
Hyaluronidase and factor VIII compositions
granted -
US 9677061
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
granted -
US 9562223
Methods for reducing intraocular pressure by administering a soluble hyaluronidase glycoprotein (sHASEGP)
granted -
US 9458442
Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
granted -
US 9447401
PH20 polypeptide variants, formulations and uses thereof
granted -
US 9333244
Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia
granted -
US 9284543
Neutral active soluble truncated PH20 polypeptides and uses thereof
granted -
US 9278124
Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
granted -
US 9211315
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
granted -
US 9034323
Method for control of post-prandial glucose
granted -
US 8927249
Extended soluble PH20 polypeptides and uses thereof
granted